Peter Ashcroft,   ETH Zürich

About me

I am a postdoc researcher in theoretical biology. What that means is I spend a lot of time in front of my computer, whilst trying to maintain relationships with practitioners in the life sciences. The rest of my time is spent worrying about a career in science and academia, and questioning why it is so hard to find brown sugar here in Switzerland.

I fulfil many roles in this position: modeller, data analyst, programmer, supercomputer tamer, …. However, with a background in mathematics and physics I also enjoy the analytical side of life. Quantitative biologist may be overselling my life-science credentials, but it is a catchy title so I will stick with it.

I specialise in combining all of the above approaches: creating models that are simple enough to be analysed mathematically and simulated efficiently, whilst still maintaining some contact with reality. The greatest satisfaction comes when the mathematics tells you something unknown about computational results, and these results combined provide new insights into the workings of the world.

My research

Hematopoiesis

The human hematopoietic system produces 1011 cells per day, which emerge from relatively rare hematopoietic stem cells. A complex division tree has evolved to allow multiple cell types to be produced and to amplify the cell numbers. This structure can also prevent the accumulation of mutations, which are inevitable given the huge number of divisions per day. By combining experimental data and mathematical models, we hope to reconstruct this tree and to understand the impact that ageing and disease have on the hematopoietic system.

This project is in collaboration with the Division of Hematology at University Hospital Zürich, and is part of a larger SystemsX.ch project between ETH Zürich, University Hospital Zürich, and University Hospital Basel.

Further sub-projects relate to the dynamics of hematopoietic stem cells, in particular how the effects of disease spread, transplantation, and host conditioning.

Cancer dynamics and treatment

Cancer is a genetic disease, requiring multiple alterations to the genome to initiate uncontrolled proliferation. Mathematical models have long been used to further our understanding of this malignancy, and can help us understand cancer initiation, progresssion, and evolution. They can also inform us about the efficacy of treatment strategies, both in terms of clearance of the disease and preventing the emergence of drug resistance.

My interests here lie in understanding the initiation of cancer in stem cells and in tissue, and in treatment strategies which prevent the accumulation of drug-resistant cancer cells.

Evolutionary dynamics and game theory

Interactions between individuals in a population can be complex, and may depend on the current state of the population. The framework of evolutionary game theory has been developed to capture these scenarios and their emergent phenomena. I approach this problem from two sides: Firstly, it is a playground for combining methods from mathematics and physics to arrive at an improved understanding. Secondly, I like to bring the problem (a little bit) closer to reality, by considering the impact of environmental variation and non-constant populations.

And then there's more…

→ Analytical methods and approximations for mutant number distributions.
→ Lifetimes in individual-based processes.
→ Combining environmental and population dynamics.
→ …

COVID-19

quarantine duration

There is ongoing debate about the appropriate duration of quarantine, particularly since the fraction of individuals who eventually test positive is perceived as being low. We use empirically-determined distributions of incubation period, infectivity, and generation time to quantify how the duration of quarantine affects onward transmission from traced contacts of confirmed SARS-CoV-2 cases and from returning travellers. We also consider the roles of testing followed by release if negative (test-and-release), reinforced hygiene, adherence, and symptoms in calculating quarantine efficacy. We show that there are quarantine strategies based on a test-and-release protocol that, from an epidemiological viewpoint, perform almost as well as a 10 day quarantine, but with fewer person days spent in quarantine. The findings apply to both travellers and contacts, but the specifics depend on the context.

This methodology has been used by the Swiss COVID-19 Science Task Force in policy briefs relating to quarantine duration, cost, and strategy comparison as well as by the European Center for Disease Control (ECDC) for their air travel quarantine guidance. From 08.02.2021, the seven day test-and-release strategy will be used in Switzerland.

Peter Ashcroft, Sonja Lehtinen, Daniel C. Angst, Nicola Low, Sebastian Bonhoeffer
Quantifying the impact of quarantine duration on COVID-19 transmission
eLife (2021) (DOI: 10.7554/eLife.63704)
eLife
medRxiv
GitHub
Shiny app
PDF
test-trace-isolate-quarantine (TTIQ)

Peter Ashcroft, Sonja Lehtinen, Sebastian Bonhoeffer
Quantifying the impact of test-trace-isolate-quarantine (TTIQ) strategies on COVID-19 transmission
medRxiv (2020) (DOI: 10.1101/2020.12.04.20244004)
medRxiv
GitHub
Shiny app
infectivity profile correction

The infectivity profile describes infectiousness relative to symptom onset time. In He et al. Nat. Med. (2020), it was calculated from the empirical serial interval distribution and incubation period distribution. However, I discovered a critical error in the code which, when corrected, resulted in a very different infectivity profile.

This story was covered by NZZ am Sonntag. Eventually a formal correction was made to the He et al. article.

Peter Ashcroft, Jana S. Huisman, Sonja Lehtinen, Judith A. Bouman, Christian L. Althaus, Roland R. Regoes, Sebastian Bonhoeffer
COVID-19 infectivity profile correction
Swiss Med Wkly. 150 (2020) (DOI: 10.4414/smw.2020.20336)
Swiss Med Wkly.
GitHub
PDF
serial intervals, infectivity profiles, and generation times

The generation time distribution, a critical factor in the dynamics and controllability of an epidemic, is often estimated based on the serial interval distribution (distribution of time intervals between symptom onset of an infector and an infectee). The different approaches to this calcuation make different -- and not always explicitly stated -- assumptions about the relationship between infectiousness and symptoms, resulting in different generation time distributions with the same mean but unequal variances. Here, we clarify the assumptions that each approach makes.

Sonja Lehtinen, Peter Ashcroft, Sebastian Bonhoeffer
On the relationship between serial interval, infectiousness profile and generation time
J. R. Soc. Interface 18 (2021) (DOI: 10.1098/rsif.2020.0756)
J. R. Soc. Interface
medRxiv
PDF
icumonitoring.ch

icumonitoring.ch is a platform to follow in near-real time beds/ventilators occupancy in intensive care units (ICU) in Switzerland during the COVID19 epidemic. The platform offers projections of ICU occupancy 3- and 7-days ahead by Regions, Cantons, and hospitals. This platform now features on SRF's COVID-19 platform.

I predict ICU bed occupancy in Switzerland due to the current COVID-19 pandemic. In particular, I quantify the risk of exceeding ICU capacity under different epidemic scenarios including a second wave of infections.

icumonitoring.ch
methodology

Publications

For approximate citometrics, check my Google Scholar account:

Google Scholar

2021

  1. Sarah Kadelka, Judith A. Bouman, Peter Ashcroft, Roland R> Regoes
    Comment on Buss et al., Science 2021: An alternative, empirically-supported adjustment for sero-reversion yields a 10 percentage point lower estimate of the cumulative incidence of SARS-CoV-2 in Manaus by October 2020
    arXiv (2021) (URL: https://arxiv.org/abs/2103.13951)
    arXiv
    PDF
  2. Damien Luque Paz, Peter Ashcroft, Radek Skoda
    Myeloproliferative Neoplasms: The Long Wait for JAK2-Mutant Clone Expansion
    Cell Stem Cell 28 (2021) (DOI: 10.1016/j.stem.2021.02.018)
    CSC
    PDF

2020

  1. Peter Ashcroft, Sonja Lehtinen, Sebastian Bonhoeffer
    Quantifying the impact of test-trace-isolate-quarantine (TTIQ) strategies on COVID-19 transmission
    medRxiv (2021) (DOI: 10.1101/2020.12.04.20244004)
    medRxiv
    PDF
  2. Peter Ashcroft, Sonja Lehtinen, Daniel C. Angst, Nicola Low, Sebastian Bonhoeffer
    Quantifying the impact of quarantine duration on COVID-19 transmission
    eLife 10 (2021) (DOI: 10.7554/eLife.63704)
    eLife
    medRxiv
    PDF
  3. Sonja Lehtinen, Peter Ashcroft, Sebastian Bonhoeffer
    On the relationship between serial interval, infectiousness profile and generation time
    J. R. Soc. Interface 18 (2021) (DOI: 10.1098/rsif.2020.0756)
    Royal Society
    medRxiv
    PDF
  4. Peter Ashcroft, Jana S. Huisman, Sonja Lehtinen, Judith A. Bouman, Christian L. Althaus, Roland R. Regoes, Sebastian Bonhoeffer
    COVID-19 infectivity profile correction
    Swiss Med Wkly. 150 (2020) (DOI: 10.4414/smw.2020.20336)
    SMW
    arXiv
    PDF
  5. Ronny Nienhold, Peter Ashcroft, Jakub Zmajkovic, Shivam Rai, Nageswara Rao Tata, Beatrice Drexler, Sara Christina Meyer, Pontus Lundberg, Jakob R. Passweg, Danijela Lekovic, Vladan P. Cokic, Sebastian Bonhoeffer, Radek C. Skoda
    MPN patients with low mutant JAK2 allele burden show late expansion restricted to erythroid and megakaryocytic lineages
    Blood 136 (2020) (DOI: 10.1182/blood.2019002943)
    Blood
    PDF

2019

  1. Lei Sun*, Peter Ashcroft*, Martin Ackermann, Sebastian Bonhoeffer
    Stochastic gene expression influences the selection of antibiotic resistance mutations
    Mol. Biol. Evol. 37 (2020) (DOI: 10.1093/molbev/msz199)
    MBE
    bioRxiv
    PDF

2018

  1. Jeffrey West, Derek Park, Cathal Harmon, Drew Williamson, Peter Ashcroft, Davide Maestrini, Alexandra Ardaseva, Rafael Bravo, Prativa Sahoo, Hung Khong, Kimberly Luddy, Mark Robertson-Tessi
    Evolutionary exploitation of PD-L1 expression in hormone receptor positive breast cancer
    bioRxiv (DOI: 10.1101/454447)
    bioRxiv
    PDF

2017

  1. Peter Ashcroft, Markus G. Manz, and Sebastian Bonhoeffer
    Clonal dominance and transplantation dynamics in hematopoietic stem cell compartments
    PLoS Comput. Biol. 13 (2017) (DOI: 10.1371/journal.pcbi.1005803)
    PLoS
    arXiv
    PDF
  2. Peter Ashcroft, Casandra E.R. Smith, Matthew Garrod, Tobias Galla
    Effects of population growth on the success of invading mutants
    J. Theor. Biol. 420 (2017) (DOI: 10.1016/j.jtbi.2017.03.014)
    Elsevier
    arXiv
    PDF

2016

  1. Peter Ashcroft
    The statistical physics of fixation and equilibration in individual-based models
    Springer International Publishing, Switzerland (2016) (DOI: 10.1007/978-3-319-41213-9)
    Springer
    PDF

2015

  1. Peter Ashcroft, Arne Traulsen, Tobias Galla
    When the mean is not enough: Calculating fixation time distributions in birth-death processes
    Phys. Rev. E 92, 042154 (2015) (DOI: 10.1103/PhysRevE.92.042154)
    APS
    arXiv
    PDF
  2. Peter Ashcroft, Franziska Michor, Tobias Galla
    Stochastic tunneling and metastable states during the somatic evolution of cancer
    Genetics 199, 1213-1228 (2015) (DOI: 10.1534/genetics.114.171553)
    Genetics
    arXiv
    PDF

2014

  1. Peter Ashcroft, Philipp M. Altrock, Tobias Galla
    Fixation in finite populations evolving in fluctuating environments
    J. R. Soc. Interface 11, 20140663 (2014) (DOI: 10.1098/rsif.2014.0663)
    Royal Society
    arXiv
    PDF

2013

  1. Peter Ashcroft and Tobias Galla
    Pattern formation in individual-based systems with time-varying parameters
    Phys. Rev. E 88, 062104 (2013) (DOI: 10.1103/PhysRevE.88.062104)
    APS
    arXiv
    PDF

Apps

I used R-shiny a couple of times to make my work interactive. Here's a couple of examples:

MPN clonal fraction
PDL-1

Code

A lot of my code is stored on the ETH GitLab server, so isn't publicly available while in development.

But I keep some things on my public GitHub account, including this webpage:

GitHub

Gists

Here's a few pieces of code that I use frequently and find handy to keep around.

Tricks

Here is some mathematical tricks that I have uncovered along the way.

Likelihood of mean vs replicates

Is the likelihood of the a set of replicate observations equivalent to the likelihood of the mean of those replicates?

PDF

St. Petersburg paradox

What is the probability of running out of money in a game with infinite expected return?

PDF
Notebook

CV

  • 2015 — present: PostDoc with Sebastian Bonhoeffer in Theoretical Biology at ETH Zürich.
  • 2012 — 2015: PhD with Tobias Galla in the Complex Systems and Statistical Physics group at The University of Manchester, UK.
  • 2008 — 2012: Undergraduate Maths and Physics degree (M.Math and Phys) at The University of Manchester, UK.

Contact

You can email me at peter.ashcroft(at)env.ethz.ch.

Occasionly I tweet

Further details can be found on our groups page:

tb.ethz.ch

My natural habitat is located in the Umweltsystemwissenschaften department at ETH Zürich, and my niche is:
 CHN H74
 Universitätstrasse 16
 8092 Zürich
 Switzerland

For fun

Academic Genealogy

Peter Ashcroft ← Tobias Galla ← David Sherrington ← Samuel Edwards ← Julian Schwinger ← Isidor Isaac Rabi ← Albert Potter Wills ← Arthur Gordon Webster ← Hermann von Helmholtz

This information is made available by the Mathematics Genealogy Project:

MGP

Cycling

You can see what I get up to on two wheels here → Strava

Website designed and composed with much pain by Peter Ashcroft.
(For unknown reasons I wanted to learn some HTML/CSS/JavaScript, so I followed courses on Codecademy and then built this site)